Literature DB >> 12680739

Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man.

Torsten Passie1, Matthias Karst, Mathias Borsutzky, Birgitt Wiese, Hinderk M Emrich, Udo Schneider.   

Abstract

The role of the N-methyl-D-aspartate (NMDA) neurotransmitter system in relation to psychoses is not completely understood, but represent a challenge in neurobiological research. The psychotic states induced by NMDA antagonists such as phencyclidine and ketamine have been described as being most similar to schizophrenia and the NMDA system has been implicated in the pathogenesis of schizophrenia. Binocular depth inversion, an illusion of visual perception, has been shown to be impaired in psychotic and psychotomimetic states in healthy and schizophrenic subjects. In this study, pictures of natural and artificial objects were presented stereoscopically to 12 healthy male volunteers and depth perception assessed using an operationalized method. The effects of the psychotomimetic S-enantiomer of the anaesthetic ketamine in two different subanaesthetic doses were compared with those of a placebo. In spite of dose dependence and grave subjective and significant objective psychopathology, no significant impairment of binocular depth perception was found with (S)-ketamine. Implications related to memory function, perceptogenesis and 'bottom-up' processing in ketamine model psychosis and schizophrenia are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12680739     DOI: 10.1177/0269881103017001698

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  8 in total

Review 1.  Toward a neurobiology of delusions.

Authors:  P R Corlett; J R Taylor; X-J Wang; P C Fletcher; J H Krystal
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

Review 2.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

3.  Alterations in interhemispheric gamma-band connectivity are related to the emergence of auditory verbal hallucinations in healthy subjects during NMDA-receptor blockade.

Authors:  Stephanie Thiebes; Saskia Steinmann; Stjepan Curic; Nenad Polomac; Christina Andreou; Iris-Carola Eichler; Lars Eichler; Christian Zöllner; Jürgen Gallinat; Gregor Leicht; Christoph Mulert
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

4.  The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia.

Authors:  Garry D Honey; Chris O'loughlin; Danielle C Turner; Edith Pomarol-Clotet; Philip R Corlett; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2006-02       Impact factor: 7.853

5.  Exploring the impact of ketamine on the experience of illusory body ownership.

Authors:  Hannah L Morgan; Danielle C Turner; Philip R Corlett; Anthony R Absalom; Ram Adapa; Fernando S Arana; Jennifer Pigott; Jenny Gardner; Jessica Everitt; Patrick Haggard; Paul C Fletcher
Journal:  Biol Psychiatry       Date:  2010-10-13       Impact factor: 13.382

6.  Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Katherine Beck; Guy Hindley; Faith Borgan; Cedric Ginestet; Robert McCutcheon; Stefan Brugger; Naomi Driesen; Mohini Ranganathan; Deepak Cyril D'Souza; Matthew Taylor; John H Krystal; Oliver D Howes
Journal:  JAMA Netw Open       Date:  2020-05-01

Review 7.  From drugs to deprivation: a Bayesian framework for understanding models of psychosis.

Authors:  P R Corlett; C D Frith; P C Fletcher
Journal:  Psychopharmacology (Berl)       Date:  2009-05-28       Impact factor: 4.530

8.  The computational anatomy of psychosis.

Authors:  Rick A Adams; Klaas Enno Stephan; Harriet R Brown; Christopher D Frith; Karl J Friston
Journal:  Front Psychiatry       Date:  2013-05-30       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.